158 related articles for article (PubMed ID: 27268630)
21. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.
Sezer O; Niemöller K; Eucker J; Jakob C; Kaufmann O; Zavrski I; Dietel M; Possinger K
Ann Hematol; 2000 Oct; 79(10):574-7. PubMed ID: 11100749
[TBL] [Abstract][Full Text] [Related]
22. [Proliferative activity of myeloma cells determined by Ki-67 antibody: biological and clinical significance].
Marković O; Marisavljević D; Cemerikić V; Vidović A; Bakrac M; Perunicić M; Suvajdzić N; Colović M
Vojnosanit Pregl; 2005 Jan; 62(1):33-8. PubMed ID: 15715347
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.
Markovic O; Marisavljevic D; Cemerikic V; Suvajdzic N; Milic N; Colovic M
Med Oncol; 2004; 21(1):73-80. PubMed ID: 15034217
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of telomerase activity in multiple myeloma.
Shiratsuchi M; Muta K; Abe Y; Motomura S; Taguchi F; Takatsuki H; Uike N; Umemura T; Nawata H; Nishimura J
Cancer; 2002 Apr; 94(8):2232-8. PubMed ID: 12001122
[TBL] [Abstract][Full Text] [Related]
25. Morphometric study of microvessels in primary CNS tumors and its correlation with tumor types and grade.
Deb P; Boruah D; Dutta V
Microvasc Res; 2012 Jul; 84(1):34-43. PubMed ID: 22465694
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors.
Sharma SG; Aggarwal N; Gupta SD; Singh MK; Gupta R; Dinda AK
Int Urol Nephrol; 2011 Mar; 43(1):125-9. PubMed ID: 20535637
[TBL] [Abstract][Full Text] [Related]
27. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis.
Munshi NC; Wilson C
Semin Oncol; 2001 Dec; 28(6):565-9. PubMed ID: 11740810
[TBL] [Abstract][Full Text] [Related]
28. Assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Antic D; Jovanovic MP; Fekete MD; Cokic V
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):353-6. PubMed ID: 20182346
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
30. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
31. Bcl-xl expression in multiple myeloma.
Peeters SD; Hovenga S; Rosati S; Vellenga E
Med Oncol; 2005; 22(2):183-90. PubMed ID: 15965282
[TBL] [Abstract][Full Text] [Related]
32. Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.
Hironaka S; Hasebe T; Kamijo T; Ohtsu A; Boku N; Yoshida S; Saitoh H; Ochiai A
Clin Cancer Res; 2002 Jan; 8(1):124-30. PubMed ID: 11801548
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography.
Choi JY; Jang KT; Shim YM; Kim K; Ahn G; Lee KH; Choi Y; Choe YS; Kim BT
Ann Surg Oncol; 2006 Aug; 13(8):1054-62. PubMed ID: 16865594
[TBL] [Abstract][Full Text] [Related]
34. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.
Babarović E; Valković T; Štifter S; Budisavljević I; Seili-Bekafigo I; Duletić-Načinović A; Lučin K; Jonjić N
Am J Clin Pathol; 2012 Jun; 137(6):870-8. PubMed ID: 22586045
[TBL] [Abstract][Full Text] [Related]
35. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
36. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.
Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L
Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
38. High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity.
Devetzoglou M; Vyzoukaki R; Kokonozaki M; Xekalou A; Pappa CA; Papadopoulou A; Alegakis A; Androulakis N; Alexandrakis MG
Tumour Biol; 2015 Nov; 36(11):8491-7. PubMed ID: 26026586
[TBL] [Abstract][Full Text] [Related]
39. Microvessel density in renal cell carcinoma: lack of prognostic significance.
MacLennan GT; Bostwick DG
Urology; 1995 Jul; 46(1):27-30. PubMed ID: 7604476
[TBL] [Abstract][Full Text] [Related]
40. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
